These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8950958)

  • 21. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
    Cheung D; Timmers MC; Zwinderman AH; Bel EH; Dijkman JH; Sterk PJ
    N Engl J Med; 1992 Oct; 327(17):1198-203. PubMed ID: 1357550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Regular use of inhaled beta-agonist and steroid in the therapy of asthma].
    Abe J
    Nihon Naika Gakkai Zasshi; 1992 Jun; 81(6):835-9. PubMed ID: 1357045
    [No Abstract]   [Full Text] [Related]  

  • 24. [Inhaled corticosteroid in out-patient management of asthma].
    Ishihara K
    Nihon Rinsho; 1996 Nov; 54(11):2976-81. PubMed ID: 8950940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The beta-agonist saga and its clinical relevance: on and on it goes.
    Taylor DR
    Am J Respir Crit Care Med; 2009 Jun; 179(11):976-8. PubMed ID: 19286624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical concerns with inhaled beta2-agonists: adult asthma.
    Cockcroft DW
    Clin Rev Allergy Immunol; 2006; 31(2-3):197-208. PubMed ID: 17085793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regular inhaled beta-adrenergic agonists in the treatment of bronchial asthma: beneficial or detrimental?
    Nelson HS; Szefler SJ; Martin RJ
    Am Rev Respir Dis; 1991 Aug; 144(2):249-50. PubMed ID: 1677552
    [No Abstract]   [Full Text] [Related]  

  • 28. Controversies in respiratory medicine: regular inhaled beta-agonists--clear clinical benefit or a hazard to health? (1). Beta-agonists can be used safely and beneficially in asthma.
    Twentyman OP; Higenbottam TW
    Respir Med; 1992 Nov; 86(6):471-6. PubMed ID: 1361679
    [No Abstract]   [Full Text] [Related]  

  • 29. Controversies in respiratory medicine: regular inhaled beta-agonists--clear clinical benefit or a hazard to health? (2). Why beta-agonists should not be used regularly.
    Page C; Costello J
    Respir Med; 1992 Nov; 86(6):477-9. PubMed ID: 1361680
    [No Abstract]   [Full Text] [Related]  

  • 30. Risks versus benefits of inhaled beta 2-agonists in the management of asthma.
    Lipworth BJ
    Drug Saf; 1992; 7(1):54-70. PubMed ID: 1346963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhaled beta-agonist use and life-threatening asthma.
    Newcomb RW
    Am J Respir Crit Care Med; 1995 Jul; 152(1):414. PubMed ID: 7599860
    [No Abstract]   [Full Text] [Related]  

  • 32. The current place of beta 2-agonists in the management of asthma.
    Svedmyr N
    Lung; 1990; 168 Suppl():105-10. PubMed ID: 1974666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-acting inhaled beta-agonists: to be taken regularly or as needed?
    Sears MR
    Lancet; 2000 May; 355(9216):1658-9. PubMed ID: 10905235
    [No Abstract]   [Full Text] [Related]  

  • 34. The beta-agonist controversy.
    Taylor DR; Sears MR; Cockcroft DW
    Med Clin North Am; 1996 Jul; 80(4):719-48. PubMed ID: 8676612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnosis and management of asthma].
    Koshino T
    Nihon Rinsho; 1999 Sep; 57(9):2107-12. PubMed ID: 10497414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Questions about inhaled beta 2-adrenoceptor agonists in asthma.
    Barnes PJ; Chung KF
    Trends Pharmacol Sci; 1992 Jan; 13(1):20-3. PubMed ID: 1347433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concluding remarks: can we explain the association of beta-agonists with asthma mortality? A hypothesis.
    Hancox RJ
    Clin Rev Allergy Immunol; 2006; 31(2-3):279-88. PubMed ID: 17085800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The beta 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology.
    Sears MR; Taylor DR
    Drug Saf; 1994 Oct; 11(4):259-83. PubMed ID: 7848546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. β-agonist safety and the elephant in the room?
    Williamson PA; Short PM; McKinlay L; Palmer CN; Lipworth BJ
    Thorax; 2011 Jun; 66(6):542; author reply 542-3. PubMed ID: 20530119
    [No Abstract]   [Full Text] [Related]  

  • 40. [Relation between the sialic acid/fucose ratio in airway secretions and the degree of airway remodeling in bronchial asthma--reversibility of airflow limitation by beta-agonists and airway remodeling in bronchial asthma].
    Kobayashi H; Yamauchi K; Inoue H; Tomichi N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():54-8. PubMed ID: 9216185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.